|
|
||||||||
 |
 |
 |
|
 |
|||
CLINICAL TRIAL MATERIAL MANUFACTURING |
|||
| Avrio Biopharmaceuticals, a subsidiary of Irvine Pharmaceutical Services, Inc., is dedicated to providing high quality, flexible and on-time clinical trial services. Avrio’s cGMP compliant clinical trial material manufacturing facility has been designed to allow for rapid production of early phase parenteral products. Avrio’s team has extensive experience in manufacturing clinical trial materials and are focused on the demands of the Phase I/II clinical trial programs. | |||
| The Avrio facility adds leading-edge aseptic fill and finish to Irvine’s complete product development support. | |||
| Range of Capabilities | |||
 Formulation services
|
|||
|
Analytical development
|
|||
|
Process validation
|
|||
|
cGMP aseptic filling: 1-100mL vials
|
|||
|
Toxicology batches
|
|||
|
Clinical batches
|
|||
|
Commercial manufacturing
|
|||
|
Lyophilization
|
|||
|
Terminal sterilization
|
|||
|
Inert gas purge and overlay
|
|||
|
Labeling and packaging
|
|||
| State-of-the-Art Facility | |||
|
Three cGMP filling suites
|
|||
|
Dedicated air-handling in each suite
|
|||
|
Formulation lab and pilot suite
|
|||
|
On-site QC and microbiology
|
|||
|
Video viewing of production
|
|||
|
Flexible and scalable
|
|||
|
No seasonal uncertainties
|
|||
| To learn more about Avrio Biopharmaceuticals, please visit, www.avriobiopharma.com. | |||
|
|
|||
